Locate providers:   

Voluma Featured Today on The Doctors TV

 

The best candidate for Voluma XC is someone aged 30 to 65, that's losing volume in their face. Voluma is good because it is structural and goes in deeper and it lasts a long time, up to 2 years.

Today on The Doctors TV, Dr. Alexander Rivkin demonstrates Juvederm Voluma XC, the new FDA approved facial filler.

Voluma Before and After
Photo Courtesy of www.thedoctorstv.com
"When the cheeks lose volume, the focus of the face shifts down and a person looks a little more tired, a little bit older and when you replace that volume, you really get a shift back up to the eyes." Dr Rivkin goes on to say, "Voluma is the first and only filler that's FDA approved to increase volume in the cheek area instantly."

Dr. Louis Cole, a cosmetic surgeon who uses Voluma XC in Atlanta tells us in the video below, "Voluma is the first FDA approved volumizer for mid-face volume loss. Much of the aging with 40 to 50 year old women has to do with the loss of volume in their face and this is the first approved substance that's shown to work for 2 years."



Dr. Burke, a double board certified cosmetic surgeon using Voluma in Ann Arbor Michigan, says, "as men and women age, we notice a decrease in the amount of volume, or fat, in our faces, especially in our cheeks. They can appear to sag and look flat. In past years this required invasive treatments for correction, including placement of implants. With Voluma XC, however, we can replace that fat and add a lifting effect which erases lines and provides a refreshed, more youthful appearance. Now, with this treatment, correction is done on an ambulatory basis. You can have treatment and go out to dinner that evening in most cases."

In a clinical study conducted by Allergan, 102 patients with facial volume loss each received one treatment of VOLUMA dermal filler. 6 to 18 months after the treatment, an assessment found almost 65% of patients' facial volume was rated as being 'very much improved'. And, more than 7 out of 10 patients described their facial volume as being 'very good' during 6 to 18 months following the treatment. In addition, VOLUMA is associated with having lower incidences of adverse events and allergic reactions than other facial volumizers.

"I'm excited to be offering the first FDA-approved hyaluronic acid specifically for the mid-face to patients with age-related and genetic volume loss. Voluma is an excellent addition to the line-up of non-surgical options from Allergan (others include Botox, Juvederm Ultra & Ultra Plus XC) and only expands my options for facial rejuvenation and correction. Administration is safe and the results are instant, natural-looking and long-lasting. Current studies show this revolutionary product lasts up to 2 years. This is significantly longer than any other hyaluronic acid on the market today," said Scott Thompson, a plastic surgeon who practices in the Salt Lake City area.

Dr. Rami Batniji, a Facial Plastic and Reconstructive surgeon in Newport Beach says, "it has the ability to restore age-related volume loss in the mid-face and delivers a more youthful, rejuvenated appearance ? something many of my patients seek."